# China NMPA Product Recall - Artificial hip joint prosthesis components (trade name: Pinnacle)

Source: https://www.globalkeysolutions.net/records/china_product_recall/depuy-orthopaedics-inc/80e07165-0085-4056-aa69-de9b322de5b5/
Source feed: China

> China NMPA product recall for Artificial hip joint prosthesis components (trade name: Pinnacle) by DePuy Orthopaedics, Inc. published March 10, 2017. Recall level: . DePuy Orthopaedics, Inc., a manufacturer of artificial hip joint prosthesis components, initiated a 

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: DePuy Orthopaedics, Inc. is recalling artificial hip joint prosthesis components (trade name: Pinnacle).
- Company Name: DePuy Orthopaedics, Inc.
- Publication Date: 2017-03-10
- Product Name: Artificial hip joint prosthesis components (trade name: Pinnacle)
- Recall Reason: A customer complained that they received a box of products (product model: 121712058, product batch number: H03642), but upon opening the box, they found that the actual product was (product model: 121711050, product batch number: H03632).
- Discovering Company: Johnson & Johnson (Shanghai) Medical Devices Co., Ltd.
- Manufacturing Company: DePuy Orthopaedics, Inc.
- Summary: DePuy Orthopaedics, Inc., a manufacturer of artificial hip joint prosthesis components, initiated a voluntary recall of its Pinnacle product (model 121712058, batch H03642) on February 21, 2017. This action was reported by Johnson & Johnson (Shanghai) Medical Devices Co., Ltd. The recall was prompted by a customer complaint detailing a packaging discrepancy where a box labeled for the Pinnacle product contained a different model (121711050), indicating a potential product mix-up or mispackaging. This recall was managed under the oversight of the National Medical Products Administration (NMPA) and aligns with regulatory standards, referencing the CFDA (Imported) registration. It is important to note that the affected products were reportedly not imported or sold within China, meaning no specific corrective actions were mandated for the Chinese market. However, local food and drug administrations were advised to enhance their supervision of similar medical devices. The recall primarily impacted regions including France, the UK, Australia, and Belgium.

Company: https://www.globalkeysolutions.net/companies/depuy-orthopaedics-inc/abe8ff95-754c-4e38-898b-9df32f104a7a/